Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9570527rdf:typepubmed:Citationlld:pubmed
pubmed-article:9570527lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0123759lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C2936596lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1415900lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0679058lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0439859lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1547699lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C2700640lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:9570527lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:9570527pubmed:issue3lld:pubmed
pubmed-article:9570527pubmed:dateCreated1998-5-14lld:pubmed
pubmed-article:9570527pubmed:abstractTextDNA-based immunization strategies designed to elicit cellular antitumor immunity offer an attractive alternative to protein- or peptide-based approaches. In the present study we have evaluated the feasibility of DNA vaccination for the induction of CTL reactivity to five different melanoma Ags in vitro. Cultured, monocyte-derived dendritic cells (DC) were transiently transfected with plasmid DNA encoding human MART-1/Melan-A, pMel-17/gp100, tyrosinase, MAGE-1, or MAGE-3 by particle bombardment and used to stimulate autologous PBMC responder T cells. CTL reactivity to these previously identified melanoma Ags was reproducibly generated after two or three stimulations with genetically modified DC. Co-ordinate transfection of two melanoma Ag cDNAs into DC promoted CTL responders capable of recognizing epitopes from both gene products. Coinsertion of genes encoding the Th1-biasing cytokines IL-12 or IFN-alpha consistently enhanced the magnitude of the resulting Ag-specific CTL reactivity. Importantly, DC transfected with a single melanoma Ag cDNA were capable of stimulating Ag-specific CTL reactivity restricted by multiple host MHC alleles, some of which had not been previously identified. These results support the inherent strengths of gene-based vaccine approaches that do not require prior knowledge of responder MHC haplotypes or of relevant MHC-restricted peptide epitopes. Given previous observations of in situ tumor HLA allele-loss variants, DC gene vaccine strategies may elicit a greater diversity of host therapeutic immunity, thereby enhancing the clinical utility and success of such approaches.lld:pubmed
pubmed-article:9570527pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:languageenglld:pubmed
pubmed-article:9570527pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9570527pubmed:statusMEDLINElld:pubmed
pubmed-article:9570527pubmed:monthFeblld:pubmed
pubmed-article:9570527pubmed:issn0022-1767lld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:MartinD MDMlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:LyD PDPlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:WilsonC CCClld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:WagnerS NSNlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:LotzeM TMTlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:StorkusW JWJlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:SlingluffC...lld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:RowleyLLlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:BabaDDlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:TütingTTlld:pubmed
pubmed-article:9570527pubmed:authorpubmed-author:KasamonY LYLlld:pubmed
pubmed-article:9570527pubmed:issnTypePrintlld:pubmed
pubmed-article:9570527pubmed:day1lld:pubmed
pubmed-article:9570527pubmed:volume160lld:pubmed
pubmed-article:9570527pubmed:ownerNLMlld:pubmed
pubmed-article:9570527pubmed:authorsCompleteYlld:pubmed
pubmed-article:9570527pubmed:pagination1139-47lld:pubmed
pubmed-article:9570527pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:meshHeadingpubmed-meshheading:9570527-...lld:pubmed
pubmed-article:9570527pubmed:year1998lld:pubmed
pubmed-article:9570527pubmed:articleTitleAutologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.lld:pubmed
pubmed-article:9570527pubmed:affiliationDepartment of Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, PA 15261, USA.lld:pubmed
pubmed-article:9570527pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9570527pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9570527pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed